Spirit Mist
A little-documented hybrid strain name with sparse verifiable lineage data and no peer-reviewed evidence for its reported effects.
Spirit Mist is one of those strain names that shows up on menus and seed listings without a clear paper trail. There's no peer-reviewed research on it specifically, no verified breeder disclosure of its parents, and no lab-panel database entry we can point to. Anything you read about its 'effects' is user self-report filtered through expectation and marketing. Treat the chemistry ranges below as ballpark hybrid numbers, not measured facts about this cultivar. If the label matters to you, ask the dispensary for a certificate of analysis.
Overview
Spirit Mist is a cannabis strain name that circulates on informal seed lists and dispensary menus but lacks the kind of documentation that lets us write about it with confidence. There is no entry in peer-reviewed chemotype surveys, no widely cited breeder release, and no lab dataset (that we have located) that separates it out from generic hybrid material. No data
That's not unusual. The commercial strain market produces hundreds of names per year, most of which are marketing labels rather than stable genetic lines [1]. Independent genetic work has shown that strain names on the market frequently do not correspond to distinct or consistent genotypes [2]. Spirit Mist should be read in that context: a name, not necessarily a well-defined cultivar.
Chemistry
Cannabinoids. We have not found a public certificate of analysis (COA) dataset for Spirit Mist. Modern commercial flower typically tests between roughly 15% and 25% THC, with CBD under 1% unless the line was specifically bred for CBD [3]. Any specific number attached to Spirit Mist online should be treated as a single retailer's batch result, not a strain-wide average. No data
Terpenes. Dominant terpene claims for Spirit Mist vary between vendors, with myrcene, caryophyllene, and limonene all mentioned in different listings. Without a published terpene panel we can't confirm any of them. No data
A note on folklore. The popular claim that flower with more than 0.5% myrcene is automatically "indica-like" and sedating is folklore, not established pharmacology; it traces to a self-published booklet rather than clinical data [4]. Ignore that threshold when reading Spirit Mist marketing copy. Disputed
Reported effects
Vendor descriptions of Spirit Mist typically use language like "uplifting," "dreamy," or "relaxing." These are user self-reports, not clinical findings. Anecdote
There are no strain-specific clinical trials for Spirit Mist — and, in fact, essentially none for any named recreational cultivar. Clinical cannabis research uses standardized preparations (e.g. nabiximols) or defined THC/CBD ratios, not brand names [5]. The effects you experience from a given Spirit Mist purchase depend on the actual cannabinoid and terpene content of that batch, your tolerance, dose, route of administration, and setting — not the name on the jar.
The broader indica/sativa/hybrid framework used to predict effects has also been challenged: chemotype (measured cannabinoid and terpene content) is a better predictor of subjective effect than lineage labels, and even chemotype only weakly predicts individual response [2][6]. Strong evidence
Lineage
We have not identified a verifiable breeder statement disclosing Spirit Mist's parents. Some online listings assert generic hybrid parentage, but these claims are not sourced to a named breeder with a documented release. Treat any pedigree you see as unverified. Disputed
This reflects a wider problem: strain lineage claims across the industry are frequently inconsistent, and genetic testing has repeatedly found that samples sold under the same name are not always close relatives [2]. Without a breeder's cut, tissue-culture verification, or a genotyping report, a written pedigree for Spirit Mist is just a story.
Cultivation basics
Because we don't have a verified breeder profile, there is no reliable cultivation sheet for Spirit Mist — no confirmed flowering time, stretch factor, feeding preference, or yield range. Reported flowering windows of 8–10 weeks are typical of many photoperiod hybrids and should be considered a guess rather than a specification. No data
If you're growing something sold as Spirit Mist, treat it as an unknown photoperiod hybrid: start with a moderate feed schedule, watch for stretch during the first two weeks of 12/12, and let trichome development (not a calendar) tell you when to harvest [7]. Phenotype variation between seeds of an unstable line can be significant, so don't expect uniformity.
Marketing vs. reality
What's marketing:
- Specific THC percentages attached to the strain name (batch-dependent, and lab-inflation is well documented [8]).
- Confident indica/sativa/hybrid effect predictions ( Disputed).
- Named terpene "dominance" without a COA.
- Detailed origin stories with no breeder attribution.
What's real:
- Spirit Mist is a name currently attached to some cannabis flower.
- The effects of any given jar are determined by its actual chemistry, your physiology, and your dose — not the label.
- If you want to know what you're buying, ask for the batch COA and read the cannabinoid and terpene panel yourself.
Sources
- Reported Jikomes, N. (2017). The Cannabis Strain Naming Problem. Leafly Science.
- Peer-reviewed Schwabe, A. L., & McGlaughlin, M. E. (2019). Genetic tools weed out misconceptions of strain reliability in Cannabis sativa: implications for a budding industry. Journal of Cannabis Research, 1(1), 3.
- Peer-reviewed ElSohly, M. A., Chandra, S., Radwan, M., Majumdar, C. G., & Church, J. C. (2021). A Comprehensive Review of Cannabis Potency in the United States in the Last Decade. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 6(6), 603-606.
- Reported Bienenstock, D. (2019). Is the 'indica vs. sativa' distinction bogus? Leafly and other outlets have investigated the myrcene threshold claim, which originated in Steep Hill Labs marketing rather than peer-reviewed research.
- Peer-reviewed Whiting, P. F., Wolff, R. F., Deshpande, S., et al. (2015). Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. JAMA, 313(24), 2456-2473.
- Peer-reviewed Smith, C. J., Vergara, D., Keegan, B., & Jikomes, N. (2022). The phytochemical diversity of commercial Cannabis in the United States. PLOS ONE, 17(5), e0267498.
- Book Cervantes, J. (2015). The Cannabis Encyclopedia: The Definitive Guide to Cultivation & Consumption of Medical Marijuana. Van Patten Publishing.
- Peer-reviewed Jikomes, N., & Zoorob, M. (2018). The Cannabinoid Content of Legal Cannabis in Washington State Varies Systematically Across Testing Facilities and Popular Consumer Products. Scientific Reports, 8, 4519.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.
Related
- Myrcene — The most common monoterpene in cannabis, blamed and credited for a lot of things it probab...